The Heart Cancer Paradox

Primary cancers of the heart are among the rarest human malignancies despite the heart’s extraordinary metabolic demand and lifelong mechanical stress. This observation raises fundamental questions about mitochondrial quality control, cellular adaptation to stress, and tissue-specific regulation of disease susceptibility.

ICM Therapeutics is exploring how mitochondrial biology and bioenergetic regulation influence disease behavior across different tissues and organ systems.